NO900991D0 - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivaterInfo
- Publication number
- NO900991D0 NO900991D0 NO900991A NO900991A NO900991D0 NO 900991 D0 NO900991 D0 NO 900991D0 NO 900991 A NO900991 A NO 900991A NO 900991 A NO900991 A NO 900991A NO 900991 D0 NO900991 D0 NO 900991D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- piperazinyl
- derivatives
- preparation
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5254489 | 1989-03-03 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO900991D0 true NO900991D0 (no) | 1990-03-01 |
NO900991L NO900991L (no) | 1990-09-04 |
NO177095B NO177095B (no) | 1995-04-10 |
NO177095C NO177095C (no) | 1995-07-19 |
Family
ID=12917732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO900991A NO177095C (no) | 1989-03-03 | 1990-03-01 | Analogifremgangsmåte for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater |
Country Status (15)
Country | Link |
---|---|
US (1) | US5021421A (no) |
EP (1) | EP0385237B1 (no) |
KR (1) | KR0149649B1 (no) |
AT (1) | ATE107922T1 (no) |
AU (1) | AU623981B2 (no) |
CA (1) | CA2011346C (no) |
DD (1) | DD292909A5 (no) |
DE (1) | DE69010232T2 (no) |
DK (1) | DK0385237T3 (no) |
ES (1) | ES2058630T3 (no) |
FI (1) | FI94413C (no) |
HK (1) | HK1005872A1 (no) |
HU (1) | HU204810B (no) |
NO (1) | NO177095C (no) |
RU (1) | RU2075478C1 (no) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041443A (en) * | 1989-02-21 | 1991-08-20 | Dainippon Pharmaceutical Co., Ltd. | Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof |
US5747493A (en) * | 1993-06-25 | 1998-05-05 | Pola Chemical Industries, Inc. | Dopamine re-uptake inhibitor |
CA2144669A1 (en) * | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
US6458789B1 (en) * | 1999-09-29 | 2002-10-01 | Lion Bioscience Ag | 2-aminopyridine derivatives and combinatorial libraries thereof |
MXPA04007612A (es) * | 2002-02-05 | 2004-11-10 | Novo Nordisk As | Aril- y heteroarilpiperazinas novedosas. |
MX2007012082A (es) | 2005-03-31 | 2007-11-20 | Pfizer Prod Inc | Derivados de ciclopentapiridina y tetrahidroquinolina. |
JP5121707B2 (ja) | 2005-07-04 | 2013-01-16 | ハイ ポイント ファーマシューティカルズ,エルエルシー | 新規医薬 |
JP2009537596A (ja) | 2006-05-23 | 2009-10-29 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用 |
SG163547A1 (en) | 2006-05-29 | 2010-08-30 | High Point Pharmaceuticals Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
JP5001271B2 (ja) * | 2006-06-09 | 2012-08-15 | 大日本住友製薬株式会社 | 新規テープ製剤 |
US20090192143A1 (en) * | 2006-07-14 | 2009-07-30 | Cox Christopher D | Substituted diazepan orexin receptor antagonists |
EP2578216A1 (en) | 2006-11-22 | 2013-04-10 | Seaside Therapeutics, Inc. | Methods of treating fragile x syndrome |
EP2014656A3 (en) | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
CN101531634B (zh) * | 2008-03-10 | 2013-09-18 | 北京德众万全医药科技有限公司 | 一种高纯度的布南色林及其制备方法 |
CN101530412A (zh) * | 2008-03-10 | 2009-09-16 | 北京德众万全医药科技有限公司 | 一种布南色林的药物组合物及其制备方法 |
CN101747272B (zh) * | 2008-12-02 | 2012-11-28 | 浙江华海药业股份有限公司 | 布南色林晶型b及其制备方法 |
CN101747273B (zh) * | 2008-12-02 | 2012-03-07 | 浙江华海药业股份有限公司 | 布南色林中间体的制备方法 |
CN101766626B (zh) * | 2008-12-30 | 2012-03-07 | 丽珠医药集团股份有限公司 | 一种治疗精神分裂症的含布南色林的口服制剂 |
WO2010105243A1 (en) | 2009-03-13 | 2010-09-16 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
IN2012DN00471A (no) | 2009-06-29 | 2015-06-05 | Agios Pharmaceuticals Inc | |
CN101619039B (zh) * | 2009-06-30 | 2011-04-13 | 严洁 | 2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢芳辛并[b]吡啶及其组合物 |
EP2525790B1 (en) | 2009-10-21 | 2020-05-27 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
EP2491145B1 (en) | 2009-10-21 | 2016-03-09 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
EP2603207A2 (en) | 2010-08-10 | 2013-06-19 | Lupin Limited | Oral controlled release pharmaceutical compositions of blonanserin |
CN102372673B (zh) * | 2010-08-27 | 2014-04-09 | 天津市医药集团技术发展有限公司 | 布南色林结晶及其制备方法 |
CN102093289B (zh) * | 2010-10-29 | 2012-12-19 | 常州华生制药有限公司 | 布南色林中间体的制备方法 |
CN102030707A (zh) * | 2010-11-12 | 2011-04-27 | 深圳万和制药有限公司 | 布南色林中间体的制备方法 |
RU2675656C2 (ru) | 2011-05-03 | 2018-12-21 | Аджиос Фармасьютикалз, Инк. | Способы применения активаторов пируваткиназы |
CN102827073A (zh) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
CN102827170A (zh) * | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | 治疗活性组合物和它们的使用方法 |
CN115536635A (zh) | 2012-01-06 | 2022-12-30 | 法国施维雅药厂 | 治疗活性化合物及其使用方法 |
US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
NZ706999A (en) | 2012-10-15 | 2018-12-21 | Agios Pharmaceuticals Inc | Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof |
WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
EP3019480B1 (en) | 2013-07-11 | 2020-05-06 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
NZ723859A (en) | 2014-03-14 | 2023-01-27 | Servier Lab | Pharmaceutical compositions of therapeutically active compounds and their uses |
CN104311487B (zh) * | 2014-09-22 | 2016-08-24 | 江苏正大丰海制药有限公司 | 一种布南色林晶型及其制备方法 |
DK3307271T3 (da) | 2015-06-11 | 2023-10-09 | Agios Pharmaceuticals Inc | Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer |
WO2017066566A1 (en) | 2015-10-15 | 2017-04-20 | Agios Pharmaceuticals, Inc | Combination therapy for treating malignancies |
PT3362066T (pt) | 2015-10-15 | 2021-11-16 | Celgene Corp | Terapia de combinação para tratar malignidades |
KR20190028109A (ko) | 2017-09-08 | 2019-03-18 | 연성정밀화학(주) | 블로난세린 함유 서방성 제제 |
CN110575438A (zh) * | 2018-06-07 | 2019-12-17 | 湖南省湘中制药有限公司 | 一种布南色林固体分散体的制备及其应用 |
US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
KR20210139317A (ko) | 2019-03-13 | 2021-11-22 | 오츠카 세이야쿠 가부시키가이샤 | 2급 아민을 함유하는 화합물의 아민 부분에 중수소 저급 알킬을 도입하는 방법 |
CN113698346A (zh) * | 2020-05-22 | 2021-11-26 | 湖南省湘中制药有限公司 | 一种布南色林工艺杂质b的制备方法 |
CN113698347A (zh) * | 2020-05-22 | 2021-11-26 | 湖南省湘中制药有限公司 | 一种布南色林工艺杂质f的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54128588A (en) * | 1978-03-29 | 1979-10-05 | Dainippon Pharmaceut Co Ltd | Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline |
DE3124673A1 (de) * | 1981-06-24 | 1983-01-13 | Bayer Ag, 5090 Leverkusen | Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung |
FR2602771B1 (fr) * | 1986-08-12 | 1988-11-04 | Rhone Poulenc Sante | Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent |
-
1990
- 1990-02-20 DK DK90103244.1T patent/DK0385237T3/da active
- 1990-02-20 EP EP90103244A patent/EP0385237B1/en not_active Expired - Lifetime
- 1990-02-20 DE DE69010232T patent/DE69010232T2/de not_active Expired - Lifetime
- 1990-02-20 ES ES90103244T patent/ES2058630T3/es not_active Expired - Lifetime
- 1990-02-20 AT AT90103244T patent/ATE107922T1/de not_active IP Right Cessation
- 1990-02-20 US US07/481,183 patent/US5021421A/en not_active Expired - Lifetime
- 1990-03-01 AU AU50604/90A patent/AU623981B2/en not_active Expired
- 1990-03-01 DD DD90338287A patent/DD292909A5/de unknown
- 1990-03-01 FI FI901030A patent/FI94413C/fi active IP Right Grant
- 1990-03-01 NO NO900991A patent/NO177095C/no not_active IP Right Cessation
- 1990-03-02 HU HU901275A patent/HU204810B/hu unknown
- 1990-03-02 CA CA002011346A patent/CA2011346C/en not_active Expired - Lifetime
- 1990-03-03 KR KR1019900002874A patent/KR0149649B1/ko not_active IP Right Cessation
-
1992
- 1992-11-12 RU RU92004429/04A patent/RU2075478C1/ru active
-
1998
- 1998-06-05 HK HK98105004A patent/HK1005872A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69010232T2 (de) | 1994-12-01 |
NO900991L (no) | 1990-09-04 |
FI94413C (fi) | 1995-09-11 |
US5021421A (en) | 1991-06-04 |
KR900014358A (ko) | 1990-10-23 |
HUT53361A (en) | 1990-10-28 |
DE69010232D1 (de) | 1994-08-04 |
HU901275D0 (en) | 1990-05-28 |
FI901030A0 (fi) | 1990-03-01 |
HU204810B (en) | 1992-02-28 |
FI94413B (fi) | 1995-05-31 |
HK1005872A1 (en) | 1999-01-29 |
AU5060490A (en) | 1990-09-06 |
EP0385237A3 (en) | 1991-03-20 |
ES2058630T3 (es) | 1994-11-01 |
NO177095C (no) | 1995-07-19 |
EP0385237B1 (en) | 1994-06-29 |
ATE107922T1 (de) | 1994-07-15 |
RU2075478C1 (ru) | 1997-03-20 |
KR0149649B1 (ko) | 1998-10-15 |
DD292909A5 (de) | 1991-08-14 |
CA2011346C (en) | 1999-08-03 |
EP0385237A2 (en) | 1990-09-05 |
NO177095B (no) | 1995-04-10 |
AU623981B2 (en) | 1992-05-28 |
DK0385237T3 (da) | 1994-07-25 |
CA2011346A1 (en) | 1990-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO900991D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater | |
RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
NO902214D0 (no) | Fremgangsmaate for fremstilling av n-(aryloksyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner og deres anvendelse som medikamenter. | |
NO904134D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
ATE79376T1 (de) | Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE52498T1 (de) | Amidderivate. | |
FR2800735B1 (fr) | Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation | |
DK0474243T3 (da) | 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf | |
KR910007883A (ko) | 퀴놀린 유도체, 그의 제조방법 및 용도 | |
KR960022486A (ko) | 신규 티아졸리딘-4-온 유도체 | |
NO882334D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO171786C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
KR910000755A (ko) | 세로토닌 2-수용체 길항활성을 갖는 헤테로사이클릭 화합물 | |
NZ238571A (en) | N-benzyl-n'-phenyl and -phenalkyl thioureas and pharmaceutical compositions thereof | |
ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
DE69002340T2 (de) | Pyrimidin-Derivate, 2-[4-(Alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl] mit serotoninergischer Wirkung. | |
PT96123A (pt) | Metodo de preparacao de um medicamento para tratamento da infeccao do pneumocystis carinii | |
NO903084D0 (no) | Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling. | |
IL97611A (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
TH15829A (th) | อนุพันธ์คาร์โบสไทริล | |
MX9703074A (es) | Inhibidores de sintesis de apoliproteina-b. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |